• Users Online: 127
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2022  |  Volume : 17  |  Issue : 3  |  Page : 792-798

Autoimmune disorders with special reference to Coronavirus Disease-2019


Department of Respiratory Care, College of Applied Medical Sciences in Jubail, Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi Arabia

Correspondence Address:
Dr. Swathi Gurajala
Department of Respiratory Care, College of Applied Medical Sciences in Jubail, Imam Abdul Rahman Bin Faisal University, Dammam
Kingdom of Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jdmimsu.jdmimsu_475_20

Rights and Permissions

The COVID-19 outbreak by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, was reported in late December 2019 in Wuhan, China, and has gradually evolved into a pandemic. The number of cases is increasing enormously, so is our knowledge of possible signs and symptoms, clinical manifestations, diagnosis, and management. Few cases develop complications due to excessive cytokine release and uncontrolled immune activation. Several researchers believe that the extensive organ, tissue, and cellular damage done by the virus can be due to antigenic mimicry with the human tissues and the production of autoantibodies. Recent reports of SARS-CoV-2 preceding antiphospholipid antibody syndrome, Miller Fisher syndrome, Guillain–Barré syndrome, Kawasaki syndrome, etc., provide definite examples of this virus's capability to cause the immune system dysregulation. With the rush to mass immunization against the disease, several types of vaccine candidates are in clinical trials, and the risk of developing autoimmune reactions should be considered due to host and pathogen interactions. Hence, in this review, we aim to summarize the various immune dysregulation autoimmune syndromes concerning the SARS-CoV-2 infection published to date.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed200    
    Printed20    
    Emailed0    
    PDF Downloaded21    
    Comments [Add]    

Recommend this journal